Severe peritonitis induced by methotrexate during treatment of persistent gestational trophoblastic disease

Zimmermann S, Stefan Zimmermann, Zaman K, Khalil Zaman, Anita Wolfer, Wolfer A, William Jacot, Jacot W
The oncologist · 2012 · vol. 17(8) , pp. e18–20 · doi:10.1634/theoncologist.2012-0146 · PMID:22659292 · PMC3425533
Case report OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-25 ⓘ

A case report describes a patient with persistent gestational trophoblastic disease who developed severe peritonitis as a complication during treatment with methotrexate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This letter reports a case of methotrexate-induced peritonitis in an extensively investigated patient.

My notes (saved in your browser only)

MeSH descriptors

Gestational Trophoblastic Disease Gestational Trophoblastic Disease Gestational Trophoblastic Disease Lung Neoplasms Methotrexate Peritonitis Serositis Serositis Serositis Serositis Chorionic Gonadotropin Chorionic Gonadotropin Female Humans Lung Neoplasms Lung Neoplasms Methotrexate Methotrexate Middle Aged Neoplasm Staging

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-08T09:52:27.483963+00:00
pubmed
last seen: 2026-10-08T21:10:28.861444+00:00
unpaywall
last seen: 2026-11-11T07:04:17.060302+00:00